Mary Ann Gray's Net Worth
$2.92 Million
Who is Mary Ann Gray?
Mary Ann Gray has an estimated net worth of $2.92 Million. This is based on reported shares across multiple companies, which include TETRALOGIC PHARMACEUTICALS Corp, Keros Therapeutics, Inc., Sarepta Therapeutics, Inc., RAPT Therapeutics, Inc., ACADIA PHARMACEUTICALS INC, GALENA BIOPHARMA, INC., BioAtla, Inc., Seneca Biopharma, Inc., JUNIPER PHARMACEUTICALS INC, Compass Therapeutics, Inc., DYAX CORP, SENOMYX INC, TELIK INC, and GTC BIOTHERAPEUTICS INC.
SEC CIK
Mary Ann Gray's CIK is 0001261974
Past Insider Trading and Trends
2016 was Mary Ann Gray's most active year for acquiring shares with 17 total transactions. Mary Ann Gray's most active month to acquire stocks was the month of May. 2016 was Mary Ann Gray's most active year for disposing of shares, totalling 14 transactions. Mary Ann Gray's most active month to dispose stocks was the month of December. 2016 saw Mary Ann Gray paying a total of $1,833,343.01 for 699,250 shares, this is the most they've acquired in one year. In 2014 Mary Ann Gray cashed out on 24,500 shares for a total of $388,815.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
TETRALOGIC PHARMACEUTICALS Corp No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Keros Therapeutics, Inc. (KROS) Snapshot price: $52.51
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Sarepta Therapeutics, Inc. (SRPT) Snapshot price: $128.92
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +31.40% | 2.95K |
—
|
—
| 12.36K |
Mar 7
| |||
Form 4
| +11.46% | 967 |
—
|
—
| 9.4K |
Dec 10
| |||
Form 4
| +47.74% | 2.73K |
—
|
—
| 8.44K |
Mar 3
| |||
Form 4
| +20.39% | 967 |
—
|
—
| 5.71K |
Dec 10
| |||
Form 4
| +77.77% | 2.08K |
—
|
—
| 4.74K |
Feb 28
| |||
Form 4
| +56.85% | 967 |
—
|
—
| 2.67K |
Dec 10
| |||
Form 4
| +2,401.47% | 1.63K |
—
|
—
| 1.7K |
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
RAPT Therapeutics, Inc. (RAPT) Snapshot price: $1.83
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ACADIA PHARMACEUTICALS INC (ACAD) Snapshot price: $16.07
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +12.52% | 16.64K |
$9.04 | $150,398.48 | 149.48K |
Jun 7
| |||
Form 4
|
∞
| 132.84K |
$1.33 | $176,599.52 | 132.84K |
Apr 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
$23.00 | -$102,000.00 |
0
|
Scheduled
|
Jan 13
| ||
Form 4
|
—
|
0
|
$20.60 | -$273,035.00 |
0
|
Scheduled
|
Dec 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
$14.45 | -$186,961.00 |
0
|
Scheduled
|
Aug 26
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |